Excelsior Biopharma Inc. (TPEX:6496)

Excelsior Biopharma Revenue

Excelsior Biopharma had revenue of 218.06M TWD in the quarter ending March 31, 2026, with 3.88% growth. This brings the company's revenue in the last twelve months to 906.42M, up 2.80% year-over-year. In the year 2025, Excelsior Biopharma had annual revenue of 898.26M with 4.22% growth.

• Revenue (ttm): 906.42M
• Revenue Growth: +2.80%
• P/S Ratio: 1.17
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	898.26M	36.35M	4.22%
Dec 31, 2024	861.91M	90.35M	11.71%
Dec 31, 2023	771.56M	99.80M	14.86%
Dec 31, 2022	671.76M	-666.63M	-49.81%
Dec 31, 2021	1.34B	-105.27M	-7.29%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error